Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes

Neuroscience Letters

Volumn 444, Issue 2, 2008, Pages 181-185

  Lebed, Yurii V ^a   Orlovsky, Maxim A ^a   Nikonenko, Alexander G ^a   Ushakova, Galina A ^b   Skibo, Galina G ^a  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b OLES HONCHAR DNIPRO NATIONAL UNIVERSITY   (Ukraine)

Author keywords

Astrogliosis; Diabetes mellitus; GFAP; Hippocampus; S100b; Streptozotocin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B; STREPTOZOCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DISEASE; BRAIN TISSUE; CELL COUNT; CELL LEVEL; CELL SHAPE; CELL SIZE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; DIABETES MELLITUS; ENZYME ASSAY; EXPERIMENTAL RAT; GLUCOSE METABOLISM; HIPPOCAMPUS; IMAGE ANALYSIS; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; ASTROCYTES; CELL COUNT; CELL SHAPE; CELL SIZE; DIABETES MELLITUS, EXPERIMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; NERVE GROWTH FACTORS; RATS; RATS, WISTAR; S100 PROTEINS; STREPTOZOCIN;

EID: 51349083982     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.07.094     Document Type: Article

References (23)

1. Bast T. Toward an integrative perspective on hippocampal function: from the rapid encoding of experience to adaptive behavior. Rev. Neurosci. 18 (2007) 253-281
2. Baydas G., Nedzvetskii V.S., Tuzcu M., Yasar A., and Kirichenko S.V. Increase of glial fibrillary acidic protein and S100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur. J. Pharmacol. 462 (2003) 67-71
3. 2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res. 1035 (2005) 86-93
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Brands A.M., Kessels R.P., de Haan E.H., Kappelle L.J., and Biessels G.J. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur. J. Pharmacol. 490 (2004) 159-168
6. Coleman E., Judd R., Hoe L., Dennis J., and Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48 (2004) 166-178
7. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
8. Ferguson S.C., Blane A., Wardlaw J., Frier B.M., Perros P., McCrimmon R.J., and Deary I.J. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28 (2005) 1431-1437
9. Frizzo J.K., Tramontina F., Bortoli E., Gottfried C., Leal R.B., Lengyel I., Donato R., Dunkley P.R., and Gonçalves C.A. S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12. Neurochem. Res. 29 (2004) 735-740
10. Garg R., Chaudhuri A., Munschauer F., and Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37 (2006) 267-273
11. Gispen W.H., and Biessels G.L. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000) 542-549
12. Holmes C.S., and Richman L.C. Cognitive profiles of children with insulin-dependent diabetes. J. Dev. Behav. Pediatr. 6 (1985) 323-326
13. King R.H. The role of glycation in the pathogenesis of diabetic polyneuropathy. Mol. Pathol. 54 (2001) 400-408
14. Lobsiger C.S., and Cleveland D.W. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10 (2007) 1355-1360
15. Orlovsky M.A., Spiga F., Lebed Y.V., Skibo G.G., and Lightman S.L. Early molecular events in the hippocampus of rats with streptozotocin-induced diabetes. Neurophysiology 39 (2008) 498-502
16. Pellerin L., Bouzier-Sore A.K., Aubert A., Serres S., Merle M., Costalat R., and Magistretti P.J. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 55 (2007) 1251-1262
17. Ryan C.M. Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 11 (1988) 86-93
18. Revsin Y., Saravia F., Roig P., Lima A., de Kloet E.R., Homo-Delarche F., and De Nicola A.F. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res. 1038 (2005) 22-31
19. Ushakova G.A. Involvement of calpain II in astroglial intermediate filaments degradation under neurogenic stress. Neurochemistry (Moscow) 16 (1999) 230-234
20. Ushakova G.A., Gubkina H.A., Kachur V.A., and Lepekhin E.A. Effect of experimental hyperphenylalaninemia on the postnatal rat brain. Int. J. Dev. Neurosci. 15 (1997) 29-36
21. Wang Z., and Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47 (1998) 50-56
22. Yan S.F., Ramasamy R., and Schmidt A.M. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat. Clin. Pract. Endocrinol. Metab. 4 (2008) 285-293
23. Zimmer D.B., Chessher J., Wilson G.L., and Zimmer W.E. S100A1 and S100B expression and target proteins in type I diabetes. Endocrinology 138 (1997) 5176-5183